Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$188K Sell
1,570
-88
-5% -$11.5K 0.04% 232
2025
Q4
$226K Sell
1,658
-16
-1% -$2.3K 0.05% 201
2025
Q3
$247K Sell
1,674
-79
-5% -$11K 0.06% 195
2025
Q2
$227K Buy
1,753
+248
+16% +$30K 0.06% 200
2025
Q1
$180K Buy
1,505
+46
+3% +$5.7K 0.05% 222
2024
Q4
$169K Sell
1,459
-32
-2% -$4.05K 0.05% 227
2024
Q3
$201K Buy
1,491
+5
+0.3% +$669 0.06% 210
2024
Q2
$202K Buy
1,486
+82
+6% +$11.2K 0.07% 194
2024
Q1
$181K Sell
1,404
-42
-3% -$5.08K 0.06% 200
2023
Q4
$165K Buy
1,446
+111
+8% +$11.1K 0.06% 202
2023
Q3
$122K Buy
1,335
+46
+4% +$4.74K 0.06% 221
2023
Q2
$145K Sell
1,289
-43
-3% -$4.55K 0.07% 191
2023
Q1
$139K Buy
1,332
+87
+7% +$9.09K 0.08% 179
2022
Q4
$138K Buy
1,245
+282
+29% +$29.6K 0.08% 164
2022
Q3
$84K Buy
963
+423
+78% +$38.4K 0.05% 212
2022
Q2
$42K Sell
540
-86
-14% -$7.1K 0.03% 279
2022
Q1
$53K Buy
626
+621
+12,420% +$59.5K 0.03% 281
2021
Q4
$1K Buy
+5
New +$621 ﹤0.01% 652

Other funds holding XYL

Addison Advisors's XYL Position: Q1 2026 in Review

Addison Advisors reduced its Xylem (XYL) stake by 5.3% in Q1 2026, selling an estimated $11.5K and leaving 1,570 shares worth $188K. The position accounts for 0.04% of the portfolio, ranked #232.

Addison Advisors first reported a position in XYL in Q4 2021 and has held it in 18 quarters since. The position peaked at $247K in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Addison Advisors held 1,570 shares of Xylem worth $188K as of Q1 2026.
  • Addison Advisors sold 88 Xylem shares in Q1 2026, an estimated $11.5K.
  • Xylem made up 0.04% of Addison Advisors's portfolio in Q1 2026, its #232 holding.
  • Addison Advisors first reported a position in Xylem in Q4 2021 and has held it in 18 quarters since.
  • Addison Advisors's Xylem position peaked at $247K in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.